Standout Papers

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III... 2015 2026 2018 2022 306
  1. A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study (2015)
    James M. Schuster, Lawrence D. Recht et al. Neuro-Oncology

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 82 standout
Sub-graph 1 of 23

Citing Papers

The interaction of innate immune and adaptive immune system
2024 Standout
Principles and therapeutic applications of adaptive immunity
2024 Standout
2 intermediate papers

Works of D. D. Bigner being referenced

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
2015 Standout

Author Peers

Author Last Decade Papers Cites
D. D. Bigner 1 78 231 190 170 4 343
Elma S. Hawkins 4 73 193 231 218 7 355
Yuxia Meng 86 127 104 224 8 384
Kira Downey 1 117 194 163 168 6 386
Jaime Richardson 62 167 212 203 8 309
Scott A. Bergfeld 123 147 216 91 4 367
Cristina Corbetta 3 113 142 145 122 9 340
Szilvia Désaknai 3 111 125 107 143 7 350
Enrico C. Lallana 49 227 133 119 8 341
D. Schulz 131 118 56 107 5 322
Katherine Ryan 1 110 197 75 107 5 362

All Works

Loading papers...

Rankless by CCL
2026